Association between B-type natriuretic peptide and long-term mortality in patients with acute severe hypertension visiting the emergency department
Authors:
Open Access
- 5 December 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
Abstract
B-type natriuretic peptide (BNP) is a well-established prognostic factor for cardiovascular disorders. However, the association between BNP levels and mortality in patients with acute severe hypertension remains unclear. This study aimed to investigate the association between BNP levels and long-term mortality in patients with acute severe hypertension visiting the emergency department (ED). This retrospective study included patients aged ≥ 18 years who were admitted to the ED between 2016 and 2019 with acute severe hypertension (systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 100 mmHg). Patients were categorized into tertiles according to BNP levels upon admission to the ED. Of the 3099 patients with acute severe hypertension, 6.4% in the first (lowest) tertile, 24.8% in the second tertile, and 44.4% in the third (highest) tertile of BNP died within 3-years. After adjusting for clinically relevant variables, patients in the second tertile of BNP (adjusted hazard ratio [HR], 2.64; 95% confidence interval [CI], 1.96–3.55), and patients in the third tertile of BNP (adjusted HR 4.18; 95% CI, 3.09–5.64) had a significantly higher risk of 3-year all-cause mortality than those in the first tertile of BNP. Therefore, BNP may be valuable for the initial assessment to identify high-risk patients among those with acute severe hypertension.Keywords
This publication has 26 references indexed in Scilit:
- Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysisThe Lancet Diabetes & Endocrinology, 2016
- Modest Elevation in BNP in Asymptomatic Hypertensive Patients Reflects Sub-Clinical Cardiac Remodeling, Inflammation and Extracellular Matrix ChangesPLOS ONE, 2012
- Improving the Primary Prevention of Cardiovascular Events by Using Biomarkers to Identify Individuals With Silent Heart DiseaseJACC, 2012
- N-Terminal Pro-Brain Natriuretic PeptideHypertension, 2011
- Improving Survival of Malignant Hypertension Patients Over 40 YearsAmerican Journal of Hypertension, 2009
- AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the ElectrocardiogramJACC, 2009
- State of the Art: Using Natriuretic Peptide Levels in Clinical PracticeEuropean Journal of Heart Failure, 2008
- Cardiothoracic ratio within the "normal" range independently predicts mortality in patients undergoing coronary angiographyHeart, 2007
- Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertensionInternational Journal of Cardiology, 2004
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004